Home > Insider Trading > Abcellera Biologics Inc.

Abcellera Biologics Inc. (ABCL)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks

In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read our article Billionaire...

Keep Reading →

March 26th, 2024 - Hedge Funds Insider Trading News

AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript

AbCellera Biologics Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.14. AbCellera Biologics Inc.

Keep Reading →

February 21st, 2024 - News Transcripts

16 Best Penny Stocks To Buy For 2024

The stock market’s optimism wave recently saw a break after latest data showed that the US labor market remains resilient despite consistent rate hikes to curb inflation.

Keep Reading →

December 11th, 2023 - Hedge Funds News

Billionaire Druckenmiller's 5 Stocks Picks with Huge Upside Potential

In this piece, we will take a look at billionaire Druckenmiller's 5 stocks picks with huge upside potential. If you want to read our introduction to Mr.

Keep Reading →

December 8th, 2023 - Hedge Funds News

AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to AbCellera's Third Quarter 2023 Business Update Conference Call. My name is Kate, and I will facilitate the audio portion of today's interactive broadcast.

Keep Reading →

November 3rd, 2023 - News Transcripts